Wells Fargo analyst Larry Biegelsen maintains $Alcon (ALC.US)$ with a buy rating, and maintains the target price at $105.
According to TipRanks data, the analyst has a success rate of 65.0% and a total average return of 11.5% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Alcon (ALC.US)$'s main analysts recently are as follows:
The firm maintains a positive outlook on Alcon's future performance, anticipating a mid-to-high single-digit growth trajectory into the second half of 2024/2025. This expectation is underpinned by a continued market expansion of approximately 5%, along with multiple drivers specific to the company. Additionally, the company seems well poised to reach its mid-20s EBIT margin goal by the year 2027.
The MedTech sector experienced solid returns, with healthcare providers particularly outperforming, as evidenced by a 10.5% return for a specific healthcare providers ETF. This performance aligns with the fundamental feedback from Q3, indicating that procedure volumes have been robust and demand remains vigorous. Insights from various sub-sectors suggest that the strong demand for procedures is expected to persist into 2025, bolstered by demographic trends and low unemployment rates.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
富国集团分析师Larry Biegelsen维持$Alcon (ALC.US)$买入评级，维持目标价105美元。
根据TipRanks数据显示，该分析师近一年总胜率为65.0%，总平均回报率为11.5%。
此外，综合报道，$Alcon (ALC.US)$近期主要分析师观点如下：
该公司对爱尔康的未来业绩保持乐观展望，预计到2024/2025年下半年将出现中高个位数的增长轨迹。这一预期得到了约5％的持续市场扩张以及公司特有的多种驱动因素的支持。此外，该公司似乎已做好准备，到2027年实现其20年代中期的息税前利润率目标。
医疗科技行业获得了可观的回报，医疗保健提供商的表现尤其跑赢大盘，特定医疗保健提供商ETF的10.5％的回报率就证明了这一点。这一表现与第三季度的基本反馈一致，表明手术量一直强劲，需求仍然强劲。来自各个子行业的见解表明，在人口趋势和低失业率的推动下，对手术的强劲需求预计将持续到2025年。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
